Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Evogene Ltd (NYSE:EVGN)

7.46
Delayed Data
As of May 03
 -0.04 / -0.53%
Today’s Change
5.93
Today|||52-Week Range
10.20
-7.33%
Year-to-Date
No recent news for Evogene Ltd.

Today’s Trading

Previous close7.50
Today’s open7.45
Day’s range7.45 - 7.46
Volume460
Average volume (3 months)11,765
Market cap$190.8M
Dividend yield--
Data as of 9:53am ET, 05/03/2016

Growth & Valuation

Earnings growth (last year)-17.24%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)-23.31%
P/E ratio--
Price/Sales18.22
Price/Book1.83

Competitors

 Today’s
change
Today’s
% change
IKNXIkonics Corp0.000.00%
CLSHCLS Holdings USA Inc0.000.00%
OCIPOCI Partners LP-0.20-2.77%
CCMPCabot Microelectroni...-0.04-0.10%
Data as of 4:02pm ET, 05/03/2016

Financials

Next reporting dateMay 19, 2016
EPS forecast (this quarter)-$0.11
Annual revenue (last year)$11.1M
Annual profit (last year)-$17.2M
Net profit margin-154.67%

Profile

Sector
Health Technology
Industry
Biotechnology
President &
Chief Executive Officer
Ofer Haviv
Chief Financial Officer
Eyal Leibovitz
Corporate headquarters
Rehovot, Tel Aviv

Forecasts

Partner Offers

Search for Jobs